About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 893 participants (pooled)
- Sample size
- 893
- Primary or secondary
- secondary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 August 2026
Limitations
Sponsor/manufacturer-linked authorship; pooled retrospective safety summary rather than a single prospective study; journal indexing/impact status not independently confirmed.
Cited in
Six pooled Phase I/II trials
AOD-9604 · Research finding
ModerateNo IGF-1 or antibody signal
AOD-9604 · Safety finding
Adverse-event reporting
AOD-9604 · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.